Skip to main content

Meet the Analyst: Thomas Wakim & John Hester, Bell Potter Analyst

Bell Direct
December 17, 2024

Join us as we conclude our 2024 Meet the Analyst series with a bang. Our Market Analyst, Grady Wulff, sits down with Bell Potter’s analysts John Hester and Thomas Wakim for a comprehensive discussion on the healthcare sector.

From deciphering Neuren Pharmaceuticals (ASX:NEU) share price fluctuations to anticipating the news flow that will share 2025 guidance and identifying why Telix Pharmaceuticals (ASX:TLX) and Clarity Pharmaceuticals (ASX:CU6) are stocks to watch in the new year, John and Thomas cover it all in this final episode of the year.

In this video, John and Thomas discuss:

  • (1:48): the headwinds & tailwinds facing the healthcare sector
  • (7:10): why they are bullish on Neuren
  • (13:48): opportunities in healthcare stocks for 2025
  • (15:18): what’s on their clinical data radar for the upcoming year.

Morning Bell 23 June

Paulina Peters
June 23, 2022

Morning Bell 22 June

Sophia Mavridis
June 22, 2022

Morning Bell 21 June

Paulina Peters
June 21, 2022

Morning Bell 20 June

Sophia Mavridis
June 20, 2022

Weekly Wrap 17 June

Sophia Mavridis
June 17, 2022

Morning Bell 16 June

Paulina Peters
June 16, 2022

Morning Bell 15 June

Sophia Mavridis
June 15, 2022

Morning Bell 14 June

Paulina Peters
June 14, 2022

Weekly Wrap 10 June

Sophia Mavridis
June 10, 2022

Morning Bell 9 June

Paulina Peters
June 9, 2022